Efficacy and Safety of Quetiapine compared with Valproate in the Treatment of Patients with Bipolar Disorder and Rapid Cycling
Study identifier:5077/9061
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Pilot Study of the Efficacy and Safety of Quetiapine compared with Valproate in the Treatment of Patients with Bipolar Disorder and Rapid Cycling: an open trial
Medical condition
Bipolar Disorder
Phase
Phase 3
Healthy volunteers
No
Study drug
quetiapine fumarate or valproate
Sex
All
Actual Enrollment
44
Study type
Interventional
Age
18 Years - 65 Years
Date
Study Start Date: 01 Jan 2002
Primary Completion Date: -
Study Completion Date: 01 Mar 2006
Study design
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Dec 2007 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca Germany Medical Director
AstraZeneca GmbH
